Reviva Pharmaceuticals Holdings Inc (RVPH): Exciting Pharma success with interesting...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Reviva Pharmaceuticals Holdings Inc (RVPH)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	44
Posts	10444
Boards Moderated	0
Alias Born	01/13/2016

Re: None

Thursday, 03/11/2021 12:53:25 PM

Thursday, March 11, 2021 12:53:25 PM

Exciting Pharma success with interesting Capital Structure.
Focused upon Schizophrenia..
Should be enetering 2 Phase 3 for Schizophrenia soon.

have not done the due dilligence necessary to give finality to data sets..

on quick first glance..I am not a researcher..so take everything with GRAIN OF SALT!!

i think this is being managed for purchase..my first gut feel..
will update as I learn more.
at $70,000,000 market cap ..i think its undervalued..

target for sale is $1 billion or around $50..per share..
has Warrants..rvphw..CAVEAT EMPTOR..
i THINK the rvphw could be interesting play..if buyout..

do your own due dilligence..

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent RVPH News

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/16/2024 09:32:46 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/14/2024 05:15:15 AM
Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 02/13/2024 10:00:49 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 02/02/2024 09:38:02 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/17/2023 09:05:15 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/17/2023 09:03:58 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 09:12:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 12:20:19 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/04/2023 09:03:42 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2023 09:02:41 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/17/2023 10:30:33 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:16:30 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 08:15:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2023 08:16:19 PM

More RVPH News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow